Nagayama Y - Search Results

1

Diverse efficacy of vaccination therapy using the alpha-fetoprotein gene against mouse hepatocellular carcinoma.

Saeki A, Nakao K, Nagayama Y, Yanagi K, Matsumoto K, Hayashi T, Ishikawa H, Hamasaki K, Ishii N, Eguchi K. Saeki A, et al. Among authors: nagayama y. Int J Mol Med. 2004 Jan;13(1):111-6. Int J Mol Med. 2004. PMID: 14654980

2

Exacerbation of thyroid autoimmunity by interferon alpha treatment in patients with chronic viral hepatitis: our studies and review of the literature.

Nagayama Y, Ohta K, Tsuruta M, Takeshita A, Kimura H, Hamasaki K, Ashizawa K, Nakata K, Yokoyama N, Nagataki S. Nagayama Y, et al. Endocr J. 1994 Oct;41(5):565-72. doi: 10.1507/endocrj.41.565. Endocr J. 1994. PMID: 7889118 Free article. Review.

3

Changes in the prevalence of HBeAg-negative mutant hepatitis B virus during the course of chronic hepatitis B.

Hamasaki K, Nakata K, Nagayama Y, Ohtsuru A, Daikoku M, Taniguchi K, Tsutsumi T, Sato Y, Kato Y, Nagataki S. Hamasaki K, et al. Among authors: nagayama y. Hepatology. 1994 Jul;20(1 Pt 1):8-14. doi: 10.1016/0270-9139(94)90127-9. Hepatology. 1994. PMID: 7912688

4

In vivo effect of gold compounds on thyroxine to triiodothyronine conversion by type I 5'-deiodinase in patients with rheumatoid arthritis.

Nagayama Y, Harakawa S, Taguchi A, Takeshita A, Eguchi K, Yokoyama N, Nagataki S. Nagayama Y, et al. Horm Metab Res. 1993 Dec;25(12):657-8. doi: 10.1055/s-2007-1002203. Horm Metab Res. 1993. PMID: 8119677 No abstract available.

5

Regression of hepatocellular carcinoma in vitro and in vivo by radiosensitizing suicide gene therapy under the inducible and spatial control of radiation.

Kawashita Y, Ohtsuru A, Kaneda Y, Nagayama Y, Kawazoe Y, Eguchi S, Kuroda H, Fujioka H, Ito M, Kanematsu T, Yamashita S. Kawashita Y, et al. Among authors: nagayama y. Hum Gene Ther. 1999 Jun 10;10(9):1509-19. doi: 10.1089/10430349950017842. Hum Gene Ther. 1999. PMID: 10395376

6

Adenovirus-mediated tumor suppressor p53 gene therapy for anaplastic thyroid carcinoma in vitro and in vivo.

Nagayama Y, Yokoi H, Takeda K, Hasegawa M, Nishihara E, Namba H, Yamashita S, Niwa M. Nagayama Y, et al. J Clin Endocrinol Metab. 2000 Nov;85(11):4081-6. doi: 10.1210/jcem.85.11.6941. J Clin Endocrinol Metab. 2000. PMID: 11095436

7

A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor.

Nagayama Y, Kita-Furuyama M, Ando T, Nakao K, Mizuguchi H, Hayakawa T, Eguchi K, Niwa M. Nagayama Y, et al. J Immunol. 2002 Mar 15;168(6):2789-94. doi: 10.4049/jimmunol.168.6.2789. J Immunol. 2002. PMID: 11884447

8

Distinctive gene expression of receptor-type tyrosine kinase families during rat hepatocarcinogenesis.

Kuroda H, Ohtsuru A, Futakuchi M, Kawashita Y, Nagayama Y, Fukuda E, Namba H, Shirai T, Kanematsu T, Yamashita S. Kuroda H, et al. Among authors: nagayama y. Int J Mol Med. 2002 May;9(5):473-80. Int J Mol Med. 2002. PMID: 11956651

9

p48 Overexpression enhances interferon-mediated expression and activity of double-stranded RNA-dependent protein kinase in human hepatoma cells.

Tamada Y, Nakao K, Nagayama Y, Nakata K, Ichikawa T, Kawamata Y, Ishikawa H, Hamasaki K, Eguchi K, Ishii N. Tamada Y, et al. Among authors: nagayama y. J Hepatol. 2002 Oct;37(4):493-9. doi: 10.1016/s0168-8278(02)00232-5. J Hepatol. 2002. PMID: 12217603

10

Receptor-independent augmentation of adenovirus-mediated gene transfer with chitosan in vitro.

Kawamata Y, Nagayama Y, Nakao K, Mizuguchi H, Hayakawa T, Sato T, Ishii N. Kawamata Y, et al. Among authors: nagayama y. Biomaterials. 2002 Dec;23(23):4573-9. doi: 10.1016/s0142-9612(02)00203-x. Biomaterials. 2002. PMID: 12322978

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

491 results

Search Page

Filters